Global Generic and Biosimilar Pharmaceuticals Market Growth, Trends, and Forecasts 2015-2025
The report requires updating with new data and is sent in 48 hours after order is placed.
For the global market, this report focuses on the market size of Generic and Biosimilar Pharmaceuticals in global, regional and country-level market, by regions (countries), by Type, and by Application, for the period 2015-2025. It also includes the Generic and Biosimilar Pharmaceuticals provides details and data information by players for the period 2015-2020.
According to this study, over the next five years, the Generic and Biosimilar Pharmaceuticals market is expected to be valued at US$ xx million by 2025, from xx million in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic and Biosimilar Pharmaceuticals market by product type, application, key players and key regions and countries.:
Segmentation by product type:
For the global market, this report focuses on the market size of Generic and Biosimilar Pharmaceuticals in global, regional and country-level market, by regions (countries), by Type, and by Application, for the period 2015-2025. It also includes the Generic and Biosimilar Pharmaceuticals provides details and data information by players for the period 2015-2020.
According to this study, over the next five years, the Generic and Biosimilar Pharmaceuticals market is expected to be valued at US$ xx million by 2025, from xx million in 2019.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic and Biosimilar Pharmaceuticals market by product type, application, key players and key regions and countries.:
Segmentation by product type:
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Other
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- Rest of Americas
- APAC
- China
- Japan
- Korea
- Taiwan
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Rest of APAC
- Europe
- Germany
- France
- UK
- Russia
- Italy
- Benelux
- Nordic
- Rest of Europe
- MENA
- Saudi Arabia
- UAE
- Turkey
- South Africa
- Egypt
- Roche
- Merck
- Amgen
- Sanofi-Aventis
- Johnson & Johnson
- AbbVie
- Eli Lilly
- Pfizer
- Novartis
- Novo Nordisk
- Innovent
- Ganlee
- Dong Bao
- 3sbio
- Biotech
- CP Guojian
- Gelgen
- Changchun High Tech
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 Market Overview
2.1.1 Global Generic and Biosimilar Pharmaceuticals Market Size and Forecast, 2015-2025
2.1.2 Generic and Biosimilar Pharmaceuticals Market Size and Forecast by Region, 2015 VS 2020 VS 2025
2.2 Global Generic and Biosimilar Pharmaceuticals Market Size and Forecast by Regions, 2015-2025 ($ millions)
2.3 Americas Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
2.4 APAC Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
2.5 Europe Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
2.6 MENA Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
3 GENERIC AND BIOSIMILAR PHARMACEUTICALS MARKET SIZE BY PLAYER
3.1 Global Generic and Biosimilar Pharmaceuticals Market Size by Player
3.1.1 Global Top Players Generic and Biosimilar Pharmaceuticals Revenue, 2018-2020E ($ millions)
3.1.2 Global Top Generic and Biosimilar Pharmaceuticals Players Market Share, 2018-2020E
3.2 Global Key Generic and Biosimilar Pharmaceuticals Players Rank in 2019
3.3 Global Key Generic and Biosimilar Pharmaceuticals Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
3.4.1 Competition Landscape Analysis
3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion
4 GENERIC AND BIOSIMILAR PHARMACEUTICALS SEGMENT BY TYPE
4.1 Overview
4.1.1 Monoclonal Antibodies
4.1.2 Interferon
4.1.3 Erythropoietin
4.1.4 Insulin
4.1.5 Vaccines
4.1.6 Other
4.2 Global Generic and Biosimilar Pharmaceuticals Market Size by Type, 2015-2025 ($ millions)
4.3 Monoclonal Antibodies Market Size by Region, 2015-2025 ($ millions)
4.4 Interferon Market Size by Region, 2015-2025 ($ millions)
4.5 Erythropoietin Market Size by Region, 2015-2025 ($ millions)
4.6 Insulin Market Size by Region, 2015-2025 ($ millions)
4.7 Vaccines Market Size by Region, 2015-2025 ($ millions)
4.8 Other Market Size by Region, 2015-2025 ($ millions)
5 GENERIC AND BIOSIMILAR PHARMACEUTICALS SEGMENT BY APPLICATION
5.1 Overview
5.1.1 Tumor
5.1.2 Diabetes
5.1.3 Cardiovascular
5.1.4 Hemophilia
5.1.5 Other
5.2 Global Generic and Biosimilar Pharmaceuticals Market Size by Application, 2015-2025 ($ millions)
5.3 Tumor Market Size by Region, 2015-2025 ($ millions)
5.4 Diabetes Market Size by Region, 2015-2025 ($ millions)
5.5 Cardiovascular Market Size by Region, 2015-2025 ($ millions)
5.6 Hemophilia Market Size by Region, 2015-2025 ($ millions)
5.7 Other Market Size by Region, 2015-2025 ($ millions)
6 AMERICAS
6.1 Americas Generic and Biosimilar Pharmaceuticals Market Size by Country
6.2 United States Generic and Biosimilar Pharmaceuticals Market Size
6.3 Canada Generic and Biosimilar Pharmaceuticals Market Size
6.4 Mexico Generic and Biosimilar Pharmaceuticals Market Size
6.5 Brazil Generic and Biosimilar Pharmaceuticals Market Size
7 APAC
7.1 APAC Generic and Biosimilar Pharmaceuticals Market Size by Regions
7.2 China Generic and Biosimilar Pharmaceuticals Market Size
7.3 Japan Generic and Biosimilar Pharmaceuticals Market Size
7.4 Korea Generic and Biosimilar Pharmaceuticals Market Size
7.5 Taiwan Generic and Biosimilar Pharmaceuticals Market Size
7.6 India Generic and Biosimilar Pharmaceuticals Market Size
7.7 Australia Generic and Biosimilar Pharmaceuticals Market Size
7.8 Indonesia Generic and Biosimilar Pharmaceuticals Market Size
7.9 Thailand Generic and Biosimilar Pharmaceuticals Market Size
7.10 Malaysia Generic and Biosimilar Pharmaceuticals Market Size
7.11 Philippines Generic and Biosimilar Pharmaceuticals Market Size
7.12 Vietnam Generic and Biosimilar Pharmaceuticals Market Size
8 EUROPE
8.1 Europe Generic and Biosimilar Pharmaceuticals by Country
8.2 Germany Generic and Biosimilar Pharmaceuticals Market Size
8.3 France Generic and Biosimilar Pharmaceuticals Market Size
8.4 UK Generic and Biosimilar Pharmaceuticals Market Size
8.5 Russia Generic and Biosimilar Pharmaceuticals Market Size
8.6 Italy Generic and Biosimilar Pharmaceuticals Market Size
8.7 Australia Generic and Biosimilar Pharmaceuticals Market Size
8.8 Benelux Generic and Biosimilar Pharmaceuticals Market Size
8.9 Nordic Generic and Biosimilar Pharmaceuticals Market Size
9 MENA
9.1 MENA & Africa Generic and Biosimilar Pharmaceuticals by Country
9.2 Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size
9.3 UAE Generic and Biosimilar Pharmaceuticals Market Size
9.4 Turkey Generic and Biosimilar Pharmaceuticals Market Size
9.5 South Africa Generic and Biosimilar Pharmaceuticals Market Size
9.6 Egypt Generic and Biosimilar Pharmaceuticals Market Size
10 MARKET DRIVERS, CHALLENGES AND TRENDS
10.1 Market Drivers and Impact
10.1.1 Growing Demand from Key Regions
10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Generic and Biosimilar Pharmaceuticals Product Offered
11.1.3 Roche Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Generic and Biosimilar Pharmaceuticals Product Offered
11.2.3 Merck Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Generic and Biosimilar Pharmaceuticals Product Offered
11.3.3 Amgen Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.3.4 Amgen Main Business Overview
11.3.5 Amgen Latest Developments
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Information
11.4.2 Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Product Offered
11.4.3 Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.4.4 Sanofi-Aventis Main Business Overview
11.4.5 Sanofi-Aventis Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Generic and Biosimilar Pharmaceuticals Product Offered
11.5.3 Johnson & Johnson Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Generic and Biosimilar Pharmaceuticals Product Offered
11.6.3 AbbVie Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Information
11.7.2 Eli Lilly Generic and Biosimilar Pharmaceuticals Product Offered
11.7.3 Eli Lilly Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.7.4 Eli Lilly Main Business Overview
11.7.5 Eli Lilly Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Generic and Biosimilar Pharmaceuticals Product Offered
11.8.3 Pfizer Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Generic and Biosimilar Pharmaceuticals Product Offered
11.9.3 Novartis Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Information
11.10.2 Novo Nordisk Generic and Biosimilar Pharmaceuticals Product Offered
11.10.3 Novo Nordisk Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.10.4 Novo Nordisk Main Business Overview
11.10.5 Novo Nordisk Latest Developments
11.11 Innovent
11.11.1 Innovent Company Information
11.11.2 Innovent Generic and Biosimilar Pharmaceuticals Product Offered
11.11.3 Innovent Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.11.4 Innovent Main Business Overview
11.11.5 Innovent Latest Developments
11.12 Ganlee
11.12.1 Ganlee Company Information
11.12.2 Ganlee Generic and Biosimilar Pharmaceuticals Product Offered
11.12.3 Ganlee Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.12.4 Ganlee Main Business Overview
11.12.5 Ganlee Latest Developments
11.13 Dong Bao
11.13.1 Dong Bao Company Information
11.13.2 Dong Bao Generic and Biosimilar Pharmaceuticals Product Offered
11.13.3 Dong Bao Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.13.4 Dong Bao Main Business Overview
11.13.5 Dong Bao Latest Developments
11.14 3sbio
11.14.1 3sbio Company Information
11.14.2 3sbio Generic and Biosimilar Pharmaceuticals Product Offered
11.14.3 3sbio Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.14.4 3sbio Main Business Overview
11.14.5 3sbio Latest Developments
11.15 Biotech
11.15.1 Biotech Company Information
11.15.2 Biotech Generic and Biosimilar Pharmaceuticals Product Offered
11.15.3 Biotech Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.15.4 Biotech Main Business Overview
11.15.5 Biotech Latest Developments
11.16 CP Guojian
11.16.1 CP Guojian Company Information
11.16.2 CP Guojian Generic and Biosimilar Pharmaceuticals Product Offered
11.16.3 CP Guojian Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.16.4 CP Guojian Main Business Overview
11.16.5 CP Guojian Latest Developments
11.17 Gelgen
11.17.1 Gelgen Company Information
11.17.2 Gelgen Generic and Biosimilar Pharmaceuticals Product Offered
11.17.3 Gelgen Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.17.4 Gelgen Main Business Overview
11.17.5 Gelgen Latest Developments
11.18 Changchun High Tech
11.18.1 Changchun High Tech Company Information
11.18.2 Changchun High Tech Generic and Biosimilar Pharmaceuticals Product Offered
11.18.3 Changchun High Tech Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.18.4 Changchun High Tech Main Business Overview
11.18.5 Changchun High Tech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 Market Overview
2.1.1 Global Generic and Biosimilar Pharmaceuticals Market Size and Forecast, 2015-2025
2.1.2 Generic and Biosimilar Pharmaceuticals Market Size and Forecast by Region, 2015 VS 2020 VS 2025
2.2 Global Generic and Biosimilar Pharmaceuticals Market Size and Forecast by Regions, 2015-2025 ($ millions)
2.3 Americas Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
2.4 APAC Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
2.5 Europe Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
2.6 MENA Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
3 GENERIC AND BIOSIMILAR PHARMACEUTICALS MARKET SIZE BY PLAYER
3.1 Global Generic and Biosimilar Pharmaceuticals Market Size by Player
3.1.1 Global Top Players Generic and Biosimilar Pharmaceuticals Revenue, 2018-2020E ($ millions)
3.1.2 Global Top Generic and Biosimilar Pharmaceuticals Players Market Share, 2018-2020E
3.2 Global Key Generic and Biosimilar Pharmaceuticals Players Rank in 2019
3.3 Global Key Generic and Biosimilar Pharmaceuticals Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
3.4.1 Competition Landscape Analysis
3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion
4 GENERIC AND BIOSIMILAR PHARMACEUTICALS SEGMENT BY TYPE
4.1 Overview
4.1.1 Monoclonal Antibodies
4.1.2 Interferon
4.1.3 Erythropoietin
4.1.4 Insulin
4.1.5 Vaccines
4.1.6 Other
4.2 Global Generic and Biosimilar Pharmaceuticals Market Size by Type, 2015-2025 ($ millions)
4.3 Monoclonal Antibodies Market Size by Region, 2015-2025 ($ millions)
4.4 Interferon Market Size by Region, 2015-2025 ($ millions)
4.5 Erythropoietin Market Size by Region, 2015-2025 ($ millions)
4.6 Insulin Market Size by Region, 2015-2025 ($ millions)
4.7 Vaccines Market Size by Region, 2015-2025 ($ millions)
4.8 Other Market Size by Region, 2015-2025 ($ millions)
5 GENERIC AND BIOSIMILAR PHARMACEUTICALS SEGMENT BY APPLICATION
5.1 Overview
5.1.1 Tumor
5.1.2 Diabetes
5.1.3 Cardiovascular
5.1.4 Hemophilia
5.1.5 Other
5.2 Global Generic and Biosimilar Pharmaceuticals Market Size by Application, 2015-2025 ($ millions)
5.3 Tumor Market Size by Region, 2015-2025 ($ millions)
5.4 Diabetes Market Size by Region, 2015-2025 ($ millions)
5.5 Cardiovascular Market Size by Region, 2015-2025 ($ millions)
5.6 Hemophilia Market Size by Region, 2015-2025 ($ millions)
5.7 Other Market Size by Region, 2015-2025 ($ millions)
6 AMERICAS
6.1 Americas Generic and Biosimilar Pharmaceuticals Market Size by Country
6.2 United States Generic and Biosimilar Pharmaceuticals Market Size
6.3 Canada Generic and Biosimilar Pharmaceuticals Market Size
6.4 Mexico Generic and Biosimilar Pharmaceuticals Market Size
6.5 Brazil Generic and Biosimilar Pharmaceuticals Market Size
7 APAC
7.1 APAC Generic and Biosimilar Pharmaceuticals Market Size by Regions
7.2 China Generic and Biosimilar Pharmaceuticals Market Size
7.3 Japan Generic and Biosimilar Pharmaceuticals Market Size
7.4 Korea Generic and Biosimilar Pharmaceuticals Market Size
7.5 Taiwan Generic and Biosimilar Pharmaceuticals Market Size
7.6 India Generic and Biosimilar Pharmaceuticals Market Size
7.7 Australia Generic and Biosimilar Pharmaceuticals Market Size
7.8 Indonesia Generic and Biosimilar Pharmaceuticals Market Size
7.9 Thailand Generic and Biosimilar Pharmaceuticals Market Size
7.10 Malaysia Generic and Biosimilar Pharmaceuticals Market Size
7.11 Philippines Generic and Biosimilar Pharmaceuticals Market Size
7.12 Vietnam Generic and Biosimilar Pharmaceuticals Market Size
8 EUROPE
8.1 Europe Generic and Biosimilar Pharmaceuticals by Country
8.2 Germany Generic and Biosimilar Pharmaceuticals Market Size
8.3 France Generic and Biosimilar Pharmaceuticals Market Size
8.4 UK Generic and Biosimilar Pharmaceuticals Market Size
8.5 Russia Generic and Biosimilar Pharmaceuticals Market Size
8.6 Italy Generic and Biosimilar Pharmaceuticals Market Size
8.7 Australia Generic and Biosimilar Pharmaceuticals Market Size
8.8 Benelux Generic and Biosimilar Pharmaceuticals Market Size
8.9 Nordic Generic and Biosimilar Pharmaceuticals Market Size
9 MENA
9.1 MENA & Africa Generic and Biosimilar Pharmaceuticals by Country
9.2 Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size
9.3 UAE Generic and Biosimilar Pharmaceuticals Market Size
9.4 Turkey Generic and Biosimilar Pharmaceuticals Market Size
9.5 South Africa Generic and Biosimilar Pharmaceuticals Market Size
9.6 Egypt Generic and Biosimilar Pharmaceuticals Market Size
10 MARKET DRIVERS, CHALLENGES AND TRENDS
10.1 Market Drivers and Impact
10.1.1 Growing Demand from Key Regions
10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Generic and Biosimilar Pharmaceuticals Product Offered
11.1.3 Roche Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Generic and Biosimilar Pharmaceuticals Product Offered
11.2.3 Merck Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Generic and Biosimilar Pharmaceuticals Product Offered
11.3.3 Amgen Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.3.4 Amgen Main Business Overview
11.3.5 Amgen Latest Developments
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Information
11.4.2 Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Product Offered
11.4.3 Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.4.4 Sanofi-Aventis Main Business Overview
11.4.5 Sanofi-Aventis Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Generic and Biosimilar Pharmaceuticals Product Offered
11.5.3 Johnson & Johnson Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Generic and Biosimilar Pharmaceuticals Product Offered
11.6.3 AbbVie Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Information
11.7.2 Eli Lilly Generic and Biosimilar Pharmaceuticals Product Offered
11.7.3 Eli Lilly Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.7.4 Eli Lilly Main Business Overview
11.7.5 Eli Lilly Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Generic and Biosimilar Pharmaceuticals Product Offered
11.8.3 Pfizer Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Generic and Biosimilar Pharmaceuticals Product Offered
11.9.3 Novartis Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Information
11.10.2 Novo Nordisk Generic and Biosimilar Pharmaceuticals Product Offered
11.10.3 Novo Nordisk Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.10.4 Novo Nordisk Main Business Overview
11.10.5 Novo Nordisk Latest Developments
11.11 Innovent
11.11.1 Innovent Company Information
11.11.2 Innovent Generic and Biosimilar Pharmaceuticals Product Offered
11.11.3 Innovent Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.11.4 Innovent Main Business Overview
11.11.5 Innovent Latest Developments
11.12 Ganlee
11.12.1 Ganlee Company Information
11.12.2 Ganlee Generic and Biosimilar Pharmaceuticals Product Offered
11.12.3 Ganlee Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.12.4 Ganlee Main Business Overview
11.12.5 Ganlee Latest Developments
11.13 Dong Bao
11.13.1 Dong Bao Company Information
11.13.2 Dong Bao Generic and Biosimilar Pharmaceuticals Product Offered
11.13.3 Dong Bao Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.13.4 Dong Bao Main Business Overview
11.13.5 Dong Bao Latest Developments
11.14 3sbio
11.14.1 3sbio Company Information
11.14.2 3sbio Generic and Biosimilar Pharmaceuticals Product Offered
11.14.3 3sbio Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.14.4 3sbio Main Business Overview
11.14.5 3sbio Latest Developments
11.15 Biotech
11.15.1 Biotech Company Information
11.15.2 Biotech Generic and Biosimilar Pharmaceuticals Product Offered
11.15.3 Biotech Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.15.4 Biotech Main Business Overview
11.15.5 Biotech Latest Developments
11.16 CP Guojian
11.16.1 CP Guojian Company Information
11.16.2 CP Guojian Generic and Biosimilar Pharmaceuticals Product Offered
11.16.3 CP Guojian Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.16.4 CP Guojian Main Business Overview
11.16.5 CP Guojian Latest Developments
11.17 Gelgen
11.17.1 Gelgen Company Information
11.17.2 Gelgen Generic and Biosimilar Pharmaceuticals Product Offered
11.17.3 Gelgen Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.17.4 Gelgen Main Business Overview
11.17.5 Gelgen Latest Developments
11.18 Changchun High Tech
11.18.1 Changchun High Tech Company Information
11.18.2 Changchun High Tech Generic and Biosimilar Pharmaceuticals Product Offered
11.18.3 Changchun High Tech Generic and Biosimilar Pharmaceuticals Revenue and YoY Growth, 2018-2020E
11.18.4 Changchun High Tech Main Business Overview
11.18.5 Changchun High Tech Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Research Methodology
Table 2. Data Source
Table 3. Generic and Biosimilar Pharmaceuticals Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Global Generic and Biosimilar Pharmaceuticals Market Size by Regions, 2015-2025 ($ millions)
Table 5. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Regions, 2015-2025
Table 6. Global Generic and Biosimilar Pharmaceuticals Revenue by Player, 2018-2020E ($ millions)
Table 7. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Player, 2018-2020E
Table 8. Global Key Generic and Biosimilar Pharmaceuticals Players Rank in 2019, Based on the Revenue in Generic and Biosimilar Pharmaceuticals
Table 9. Global Key Generic and Biosimilar Pharmaceuticals Players Head office and Products Offered
Table 10. Generic and Biosimilar Pharmaceuticals Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
Table 11. New Products and Potential Entrants
Table 12. Mergers & Acquisitions, Expansion
Table 13. Major Players of Monoclonal Antibodies
Table 14. Major Players of Interferon
Table 15. Major Players of Erythropoietin
Table 16. Major Players of Insulin
Table 17. Major Players of Vaccines
Table 18. Major Players of Other
Table 19. Global Generic and Biosimilar Pharmaceuticals Market Size CAGR by Type ($ millions): 2015 VS 2020 VS 2025
Table 20. Global Generic and Biosimilar Pharmaceuticals Market Size by Type, 2015-2025 ($ millions)
Table 21. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Type, 2015-2025
Table 22. Global Monoclonal Antibodies Market Size by Region, 2015-2025 ($ millions)
Table 23. Global Monoclonal Antibodies Market Size Share by Region, 2015-2025
Table 24. Global Interferon Market Size by Region, 2015-2025 ($ millions)
Table 25. Global Interferon Market Size Share by Region, 2015-2025
Table 26. Global Erythropoietin Market Size by Region, 2015-2025 ($ millions)
Table 27. Global Erythropoietin Market Size Share by Region, 2015-2025
Table 28. Global Insulin Market Size by Region, 2015-2025 ($ millions)
Table 29. Global Insulin Market Size Share by Region, 2015-2025
Table 30. Global Vaccines Market Size by Region, 2015-2025 ($ millions)
Table 31. Global Vaccines Market Size Share by Region, 2015-2025
Table 32. Global Other Market Size by Region, 2015-2025 ($ millions)
Table 33. Global Other Market Size Share by Region, 2015-2025
Table 34. Global Generic and Biosimilar Pharmaceuticals Market Size CAGR by Application ($ millions): 2015 VS 2020 VS 2025
Table 35. Global Generic and Biosimilar Pharmaceuticals Market Size by Application, 2015-2025 ($ millions)
Table 36. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Application, 2015-2025
Table 37. Global Tumor Market Size by Region, 2015-2025 ($ millions)
Table 38. Global Tumor Market Size Share by Region, 2015-2025
Table 39. Global Diabetes Market Size by Region, 2015-2025 ($ millions)
Table 40. Global Diabetes Market Size Share by Region, 2015-2025
Table 41. Global Cardiovascular Market Size by Region, 2015-2025 ($ millions)
Table 42. Global Cardiovascular Market Size Share by Region, 2015-2025
Table 43. Global Hemophilia Market Size by Region, 2015-2025 ($ millions)
Table 44. Global Hemophilia Market Size Share by Region, 2015-2025
Table 45. Global Other Market Size by Region, 2015-2025 ($ millions)
Table 46. Global Other Market Size Share by Region, 2015-2025
Table 47. Americas Generic and Biosimilar Pharmaceuticals Market Size by Country (2015-2020) ($ Millions)
Table 48. Americas Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2015-2020)
Table 49. APAC Generic and Biosimilar Pharmaceuticals Market Size by Region (2015-2020) ($ Millions)
Table 50. APAC Generic and Biosimilar Pharmaceuticals Market Size Share by Region (2015-2020)
Table 51. Europe Generic and Biosimilar Pharmaceuticals Market Size by Country (2015-2020) ($ Millions)
Table 52. Europe Generic and Biosimilar Pharmaceuticals Market Size Share by Country (2015-2020)
Table 53. MENA Generic and Biosimilar Pharmaceuticals Market Size by Country (2015-2020) ($ Millions)
Table 54. MENA Generic and Biosimilar Pharmaceuticals Market Size Share by Country (2015-2020)
Table 55. Key and Potential Regions of Generic and Biosimilar Pharmaceuticals
Table 56. Key Application and Potential Industries of Generic and Biosimilar Pharmaceuticals
Table 57. Key Challenges of Generic and Biosimilar Pharmaceuticals
Table 58. Key Trends of Generic and Biosimilar Pharmaceuticals
Table 59. Roche Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 60. Roche Generic and Biosimilar Pharmaceuticals Product Offered
Table 61. Roche Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 62. Roche Main Business
Table 63. Roche Latest Developments
Table 64. Merck Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 65. Merck Generic and Biosimilar Pharmaceuticals Product Offered
Table 66. Merck Main Business
Table 67. Merck Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 68. Merck Latest Developments
Table 69. Amgen Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 70. Amgen Generic and Biosimilar Pharmaceuticals Product Offered
Table 71. Amgen Main Business
Table 72. Amgen Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 73. Amgen Latest Developments
Table 74. Sanofi-Aventis Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 75. Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Product Offered
Table 76. Sanofi-Aventis Main Business
Table 77. Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 78. Sanofi-Aventis Latest Developments
Table 79. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 80. Johnson & Johnson Generic and Biosimilar Pharmaceuticals Product Offered
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 83. Johnson & Johnson Latest Developments
Table 84. AbbVie Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 85. AbbVie Generic and Biosimilar Pharmaceuticals Product Offered
Table 86. AbbVie Main Business
Table 87. AbbVie Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 88. AbbVie Latest Developments
Table 89. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 90. Eli Lilly Generic and Biosimilar Pharmaceuticals Product Offered
Table 91. Eli Lilly Main Business
Table 92. Eli Lilly Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 93. Eli Lilly Latest Developments
Table 94. Pfizer Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 95. Pfizer Generic and Biosimilar Pharmaceuticals Product Offered
Table 96. Pfizer Main Business
Table 97. Pfizer Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 98. Pfizer Latest Developments
Table 99. Novartis Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 100. Novartis Generic and Biosimilar Pharmaceuticals Product Offered
Table 101. Novartis Main Business
Table 102. Novartis Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 103. Novartis Latest Developments
Table 104. Novo Nordisk Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 105. Novo Nordisk Generic and Biosimilar Pharmaceuticals Product Offered
Table 106. Novo Nordisk Main Business
Table 107. Novo Nordisk Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 108. Novo Nordisk Latest Developments
Table 109. Innovent Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 110. Innovent Generic and Biosimilar Pharmaceuticals Product Offered
Table 111. Innovent Main Business
Table 112. Innovent Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 113. Innovent Latest Developments
Table 114. Ganlee Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 115. Ganlee Generic and Biosimilar Pharmaceuticals Product Offered
Table 116. Ganlee Main Business
Table 117. Ganlee Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 118. Ganlee Latest Developments
Table 119. Dong Bao Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 120. Dong Bao Generic and Biosimilar Pharmaceuticals Product Offered
Table 121. Dong Bao Main Business
Table 122. Dong Bao Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 123. Dong Bao Latest Developments
Table 124. 3sbio Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 125. 3sbio Generic and Biosimilar Pharmaceuticals Product Offered
Table 126. 3sbio Main Business
Table 127. 3sbio Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 128. 3sbio Latest Developments
Table 129. Biotech Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 130. Biotech Generic and Biosimilar Pharmaceuticals Product Offered
Table 131. Biotech Main Business
Table 132. Biotech Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 133. Biotech Latest Developments
Table 134. CP Guojian Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 135. CP Guojian Generic and Biosimilar Pharmaceuticals Product Offered
Table 136. CP Guojian Main Business
Table 137. CP Guojian Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 138. CP Guojian Latest Developments
Table 139. Gelgen Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 140. Gelgen Generic and Biosimilar Pharmaceuticals Product Offered
Table 141. Gelgen Main Business
Table 142. Gelgen Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 143. Gelgen Latest Developments
Table 144. Changchun High Tech Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 145. Changchun High Tech Generic and Biosimilar Pharmaceuticals Product Offered
Table 146. Changchun High Tech Main Business
Table 147. Changchun High Tech Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 148. Changchun High Tech Latest Developments
Table 1. Research Methodology
Table 2. Data Source
Table 3. Generic and Biosimilar Pharmaceuticals Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Global Generic and Biosimilar Pharmaceuticals Market Size by Regions, 2015-2025 ($ millions)
Table 5. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Regions, 2015-2025
Table 6. Global Generic and Biosimilar Pharmaceuticals Revenue by Player, 2018-2020E ($ millions)
Table 7. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Player, 2018-2020E
Table 8. Global Key Generic and Biosimilar Pharmaceuticals Players Rank in 2019, Based on the Revenue in Generic and Biosimilar Pharmaceuticals
Table 9. Global Key Generic and Biosimilar Pharmaceuticals Players Head office and Products Offered
Table 10. Generic and Biosimilar Pharmaceuticals Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
Table 11. New Products and Potential Entrants
Table 12. Mergers & Acquisitions, Expansion
Table 13. Major Players of Monoclonal Antibodies
Table 14. Major Players of Interferon
Table 15. Major Players of Erythropoietin
Table 16. Major Players of Insulin
Table 17. Major Players of Vaccines
Table 18. Major Players of Other
Table 19. Global Generic and Biosimilar Pharmaceuticals Market Size CAGR by Type ($ millions): 2015 VS 2020 VS 2025
Table 20. Global Generic and Biosimilar Pharmaceuticals Market Size by Type, 2015-2025 ($ millions)
Table 21. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Type, 2015-2025
Table 22. Global Monoclonal Antibodies Market Size by Region, 2015-2025 ($ millions)
Table 23. Global Monoclonal Antibodies Market Size Share by Region, 2015-2025
Table 24. Global Interferon Market Size by Region, 2015-2025 ($ millions)
Table 25. Global Interferon Market Size Share by Region, 2015-2025
Table 26. Global Erythropoietin Market Size by Region, 2015-2025 ($ millions)
Table 27. Global Erythropoietin Market Size Share by Region, 2015-2025
Table 28. Global Insulin Market Size by Region, 2015-2025 ($ millions)
Table 29. Global Insulin Market Size Share by Region, 2015-2025
Table 30. Global Vaccines Market Size by Region, 2015-2025 ($ millions)
Table 31. Global Vaccines Market Size Share by Region, 2015-2025
Table 32. Global Other Market Size by Region, 2015-2025 ($ millions)
Table 33. Global Other Market Size Share by Region, 2015-2025
Table 34. Global Generic and Biosimilar Pharmaceuticals Market Size CAGR by Application ($ millions): 2015 VS 2020 VS 2025
Table 35. Global Generic and Biosimilar Pharmaceuticals Market Size by Application, 2015-2025 ($ millions)
Table 36. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Application, 2015-2025
Table 37. Global Tumor Market Size by Region, 2015-2025 ($ millions)
Table 38. Global Tumor Market Size Share by Region, 2015-2025
Table 39. Global Diabetes Market Size by Region, 2015-2025 ($ millions)
Table 40. Global Diabetes Market Size Share by Region, 2015-2025
Table 41. Global Cardiovascular Market Size by Region, 2015-2025 ($ millions)
Table 42. Global Cardiovascular Market Size Share by Region, 2015-2025
Table 43. Global Hemophilia Market Size by Region, 2015-2025 ($ millions)
Table 44. Global Hemophilia Market Size Share by Region, 2015-2025
Table 45. Global Other Market Size by Region, 2015-2025 ($ millions)
Table 46. Global Other Market Size Share by Region, 2015-2025
Table 47. Americas Generic and Biosimilar Pharmaceuticals Market Size by Country (2015-2020) ($ Millions)
Table 48. Americas Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2015-2020)
Table 49. APAC Generic and Biosimilar Pharmaceuticals Market Size by Region (2015-2020) ($ Millions)
Table 50. APAC Generic and Biosimilar Pharmaceuticals Market Size Share by Region (2015-2020)
Table 51. Europe Generic and Biosimilar Pharmaceuticals Market Size by Country (2015-2020) ($ Millions)
Table 52. Europe Generic and Biosimilar Pharmaceuticals Market Size Share by Country (2015-2020)
Table 53. MENA Generic and Biosimilar Pharmaceuticals Market Size by Country (2015-2020) ($ Millions)
Table 54. MENA Generic and Biosimilar Pharmaceuticals Market Size Share by Country (2015-2020)
Table 55. Key and Potential Regions of Generic and Biosimilar Pharmaceuticals
Table 56. Key Application and Potential Industries of Generic and Biosimilar Pharmaceuticals
Table 57. Key Challenges of Generic and Biosimilar Pharmaceuticals
Table 58. Key Trends of Generic and Biosimilar Pharmaceuticals
Table 59. Roche Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 60. Roche Generic and Biosimilar Pharmaceuticals Product Offered
Table 61. Roche Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 62. Roche Main Business
Table 63. Roche Latest Developments
Table 64. Merck Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 65. Merck Generic and Biosimilar Pharmaceuticals Product Offered
Table 66. Merck Main Business
Table 67. Merck Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 68. Merck Latest Developments
Table 69. Amgen Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 70. Amgen Generic and Biosimilar Pharmaceuticals Product Offered
Table 71. Amgen Main Business
Table 72. Amgen Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 73. Amgen Latest Developments
Table 74. Sanofi-Aventis Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 75. Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Product Offered
Table 76. Sanofi-Aventis Main Business
Table 77. Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 78. Sanofi-Aventis Latest Developments
Table 79. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 80. Johnson & Johnson Generic and Biosimilar Pharmaceuticals Product Offered
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 83. Johnson & Johnson Latest Developments
Table 84. AbbVie Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 85. AbbVie Generic and Biosimilar Pharmaceuticals Product Offered
Table 86. AbbVie Main Business
Table 87. AbbVie Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 88. AbbVie Latest Developments
Table 89. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 90. Eli Lilly Generic and Biosimilar Pharmaceuticals Product Offered
Table 91. Eli Lilly Main Business
Table 92. Eli Lilly Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 93. Eli Lilly Latest Developments
Table 94. Pfizer Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 95. Pfizer Generic and Biosimilar Pharmaceuticals Product Offered
Table 96. Pfizer Main Business
Table 97. Pfizer Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 98. Pfizer Latest Developments
Table 99. Novartis Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 100. Novartis Generic and Biosimilar Pharmaceuticals Product Offered
Table 101. Novartis Main Business
Table 102. Novartis Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 103. Novartis Latest Developments
Table 104. Novo Nordisk Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 105. Novo Nordisk Generic and Biosimilar Pharmaceuticals Product Offered
Table 106. Novo Nordisk Main Business
Table 107. Novo Nordisk Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 108. Novo Nordisk Latest Developments
Table 109. Innovent Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 110. Innovent Generic and Biosimilar Pharmaceuticals Product Offered
Table 111. Innovent Main Business
Table 112. Innovent Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 113. Innovent Latest Developments
Table 114. Ganlee Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 115. Ganlee Generic and Biosimilar Pharmaceuticals Product Offered
Table 116. Ganlee Main Business
Table 117. Ganlee Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 118. Ganlee Latest Developments
Table 119. Dong Bao Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 120. Dong Bao Generic and Biosimilar Pharmaceuticals Product Offered
Table 121. Dong Bao Main Business
Table 122. Dong Bao Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 123. Dong Bao Latest Developments
Table 124. 3sbio Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 125. 3sbio Generic and Biosimilar Pharmaceuticals Product Offered
Table 126. 3sbio Main Business
Table 127. 3sbio Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 128. 3sbio Latest Developments
Table 129. Biotech Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 130. Biotech Generic and Biosimilar Pharmaceuticals Product Offered
Table 131. Biotech Main Business
Table 132. Biotech Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 133. Biotech Latest Developments
Table 134. CP Guojian Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 135. CP Guojian Generic and Biosimilar Pharmaceuticals Product Offered
Table 136. CP Guojian Main Business
Table 137. CP Guojian Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 138. CP Guojian Latest Developments
Table 139. Gelgen Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 140. Gelgen Generic and Biosimilar Pharmaceuticals Product Offered
Table 141. Gelgen Main Business
Table 142. Gelgen Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 143. Gelgen Latest Developments
Table 144. Changchun High Tech Details, Company Total Revenue (in $ million), Head Office, Generic and Biosimilar Pharmaceuticals Major Market Areas and Its Competitors
Table 145. Changchun High Tech Generic and Biosimilar Pharmaceuticals Product Offered
Table 146. Changchun High Tech Main Business
Table 147. Changchun High Tech Generic and Biosimilar Pharmaceuticals Revenue ($ million) and YoY Growth, 2018-2020E
Table 148. Changchun High Tech Latest Developments
LIST OF FIGURES
Figure 1. Generic and Biosimilar Pharmaceuticals Report Years Considered
Figure 2. Global Generic and Biosimilar Pharmaceuticals Market Size Growth Rate, 2015-2025 ($ millions)
Figure 3. Generic and Biosimilar Pharmaceuticals Consumption by Region (2015 VS 2020 & 2025) ($ millions)
Figure 4. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Regions, 2015-2025
Figure 5. Americas Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 6. APAC Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 7. Europe Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 8. MENA Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 9. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Player in 2019
Figure 10. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Type in 2019
Figure 11. Generic and Biosimilar Pharmaceuticals in Tumor
Figure 12. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Tumor, 2015-2025 ($ millions)
Figure 13. Generic and Biosimilar Pharmaceuticals in Diabetes
Figure 14. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Diabetes, 2015-2025 ($ millions)
Figure 15. Generic and Biosimilar Pharmaceuticals in Cardiovascular
Figure 16. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Cardiovascular, 2015-2025 ($ millions)
Figure 17. Generic and Biosimilar Pharmaceuticals in Hemophilia
Figure 18. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Hemophilia, 2015-2025 ($ millions)
Figure 19. Generic and Biosimilar Pharmaceuticals in Other
Figure 20. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Other, 2015-2025 ($ millions)
Figure 21. Americas Generic and Biosimilar Pharmaceuticals Value Market Share by Country in 2019
Figure 22. United States Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 23. Canada Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 24. Mexico Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 25. Brazil Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 26. APAC Generic and Biosimilar Pharmaceuticals Value Market Share by Region in 2019
Figure 27. China Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 28. Japan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 29. Korea Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 30. Taiwan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 31. India Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 32. Australia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 33. Indonesia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 34. Thailand Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 35. Malaysia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 36. Philippines Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 37. Vietnam Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 38. Europe Generic and Biosimilar Pharmaceuticals Value Market Share by Country in 2019
Figure 39. Germany Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 40. France Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 41. UK Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 42. Russia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 43. Italy Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 44. Australia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 45. Benelux Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 46. Nordic Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 47. MENA Generic and Biosimilar Pharmaceuticals Value Market Share by Country in 2019
Figure 48. Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 49. UAE Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 50. Turkey Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 51. South Africa Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 52. Egypt Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 1. Generic and Biosimilar Pharmaceuticals Report Years Considered
Figure 2. Global Generic and Biosimilar Pharmaceuticals Market Size Growth Rate, 2015-2025 ($ millions)
Figure 3. Generic and Biosimilar Pharmaceuticals Consumption by Region (2015 VS 2020 & 2025) ($ millions)
Figure 4. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Regions, 2015-2025
Figure 5. Americas Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 6. APAC Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 7. Europe Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 8. MENA Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 9. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Player in 2019
Figure 10. Global Generic and Biosimilar Pharmaceuticals Market Size Share by Type in 2019
Figure 11. Generic and Biosimilar Pharmaceuticals in Tumor
Figure 12. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Tumor, 2015-2025 ($ millions)
Figure 13. Generic and Biosimilar Pharmaceuticals in Diabetes
Figure 14. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Diabetes, 2015-2025 ($ millions)
Figure 15. Generic and Biosimilar Pharmaceuticals in Cardiovascular
Figure 16. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Cardiovascular, 2015-2025 ($ millions)
Figure 17. Generic and Biosimilar Pharmaceuticals in Hemophilia
Figure 18. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Hemophilia, 2015-2025 ($ millions)
Figure 19. Generic and Biosimilar Pharmaceuticals in Other
Figure 20. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth: Other, 2015-2025 ($ millions)
Figure 21. Americas Generic and Biosimilar Pharmaceuticals Value Market Share by Country in 2019
Figure 22. United States Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 23. Canada Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 24. Mexico Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 25. Brazil Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 26. APAC Generic and Biosimilar Pharmaceuticals Value Market Share by Region in 2019
Figure 27. China Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 28. Japan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 29. Korea Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 30. Taiwan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 31. India Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 32. Australia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 33. Indonesia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 34. Thailand Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 35. Malaysia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 36. Philippines Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 37. Vietnam Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 38. Europe Generic and Biosimilar Pharmaceuticals Value Market Share by Country in 2019
Figure 39. Germany Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 40. France Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 41. UK Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 42. Russia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 43. Italy Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 44. Australia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 45. Benelux Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 46. Nordic Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 47. MENA Generic and Biosimilar Pharmaceuticals Value Market Share by Country in 2019
Figure 48. Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 49. UAE Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 50. Turkey Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 51. South Africa Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
Figure 52. Egypt Generic and Biosimilar Pharmaceuticals Market Size YoY Growth, 2015-2025 ($ millions)
